Verdence Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Verdence Capital Advisors's ELV Position: Q1 2026 in Review
Verdence Capital Advisors increased its Elevance Health (ELV) stake by 16% in Q1 2026, buying an estimated $642K and bringing the position to 13,833 shares worth $4.05M. The position accounts for 0.24% of the portfolio, ranked #100.
Verdence Capital Advisors first reported a position in ELV in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.7M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Verdence Capital Advisors held 13,833 shares of Elevance Health worth $4.05M as of Q1 2026.
- Verdence Capital Advisors bought 1,952 Elevance Health shares in Q1 2026, an estimated $642K.
- Elevance Health made up 0.24% of Verdence Capital Advisors's portfolio in Q1 2026, its #100 holding.
- Verdence Capital Advisors first reported a position in Elevance Health in Q1 2022 and has held it in 17 quarters since.
- Verdence Capital Advisors's Elevance Health position peaked at $9.7M in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.